The genetic vulnerability to cisplatin ototoxicity: a systematic review.
Scientific Reports
Tserga, Evangelia E; Nandwani, Tara T; Edvall, Niklas K NK; Bulla, Jan J; Patel, Poulam P; Canlon, Barbara B; Cederroth, Christopher R CR; Baguley, David M DM
Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.
International Journal Of Molecular Sciences
Chang, Cara C; Hu, Yichun Y; Hogan, Susan L SL; Mercke, Nickie N; Gomez, Madeleine M; O'Bryant, Cindy C; Bowles, Daniel W DW; George, Blessy B; Wen, Xia X; Aleksunes, Lauren M LM; Joy, Melanie S MS
Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.
Pharmacogenomics
Lanvers-Kaminsky, Claudia C; Sprowl, Jason A JA; Malath, Ingrid I; Deuster, Dirk D; Eveslage, Maria M; Schlatter, Eberhard E; Mathijssen, Ron Hj RH; Boos, Joachim J; Jürgens, Heribert H; Am Zehnhoff-Dinnesen, Antionette G AG; Sparreboom, Alex A; Ciarimboli, Giuliano G
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.
Journal Of The National Cancer Institute
Travis, Lois B LB; Fossa, Sophie D SD; Sesso, Howard D HD; Frisina, Robert D RD; Herrmann, David N DN; Beard, Clair J CJ; Feldman, Darren R DR; Pagliaro, Lance C LC; Miller, Robert C RC; Vaughn, David J DJ; Einhorn, Lawrence H LH; Cox, Nancy J NJ; Dolan, M Eileen ME; ,